|
COVID-19 Vaccine Begins to Flow to Pharmacy Partners
|
|
If not already occurring, pharmacists should expect an onslaught of requests to receive COVID-19 vaccines now that the federal government is beginning to ship doses to its pharmacy partners. Here is more information on how much is being shipped, when it is going out, and which pharmacies are more likely to get vaccine.
|
|
|
Family Physicians Want Pharmacists to Share More Data
About Vaccinations
|
|
|
While primary care physicians are generally positive about pharmacists helping get their patients vaccinated, they have some complaints related to communication and reporting. A majority of respondents to a recent survey complained that pharmacists didn’t inform them when vaccinations were provided to their patients and also often failed to enter the information in immunization information systems. Here is more information.
|
|
No Difference in Outcomes With Recommended
ICU Sedatives
|
|
|
With shortages of drugs used to sedate mechanically ventilated patients during the COVID-19 pandemic, hospital pharmacists often have had to grapple with healthcare providers being unable to get their sedative of choice. If it was a question of dexmedetomidine and propofol, a new study finds that it likely didn’t make a difference. Find out how little results differed between sepsis patients on ventilators when they received either of the drugs.
|
|
|
Prolonged Use of Synthetic Progestogen Strongly Linked to
Brain Tumors
|
|
While past research has hinted at a link, a new study provides good-quality evidence on a link between the hormone drug cyproterone acetate and the development of brain tumors. In a study of more than 250,000 women, French researchers emphasize that the risk increases with higher doses and longer exposure. Here are more details.
|
|
